Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-02
DOI
10.3389/fcimb.2019.00083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergy between Pyrvinium Pamoate and Azoles against Exophiala dermatitidis
- (2018) Lujuan Gao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris
- (2018) Milena Kordalewska et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease
- (2018) Gemma L. Nixon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017
- (2018) Anke Kohlenberg et al. Eurosurveillance
- Candida auris : An emerging drug resistant yeast – A mini-review
- (2018) A.L. Bidaud et al. JOURNAL DE MYCOLOGIE MEDICALE
- An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital
- (2018) Alba Ruiz-Gaitán et al. MYCOSES
- Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development
- (2018) Gina Wall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options
- (2018) Janaina de Cássia Orlandi Sardi et al. MICROBIAL PATHOGENESIS
- Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey
- (2018) Nancy A Chow et al. LANCET INFECTIOUS DISEASES
- A Candida auris Outbreak and Its Control in an Intensive Care Setting
- (2018) David W. Eyre et al. NEW ENGLAND JOURNAL OF MEDICINE
- Candida auris: a worrisome, globally emerging pathogen
- (2017) Bhagyashri D. Navalkele et al. Expert Review of Anti-Infective Therapy
- Candida auris : An emerging multidrug-resistant pathogen
- (2017) David Sears et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The Drug Repurposing Hub: a next-generation drug library and information resource
- (2017) Steven M Corsello et al. NATURE MEDICINE
- In vitro and in vivo effects of suloctidil on growth and biofilm formation of the opportunistic fungus Candida albicans
- (2017) Beini Zeng et al. Oncotarget
- Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
- (2017) Anuradha Chowdhary et al. PLoS Pathogens
- Fluconazole resistance in Candida species: a current perspective
- (2017) Elizabeth Berkow et al. Infection and Drug Resistance
- Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
- (2016) Shawn R. Lockhart et al. CLINICAL INFECTIOUS DISEASES
- New clinical phenotypes of fungal infections in special hosts
- (2016) B. Pilmis et al. CLINICAL MICROBIOLOGY AND INFECTION
- EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
- (2016) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Multidrug-resistant Candida auris : ‘new kid on the block’ in hospital-associated infections?
- (2016) A. Chowdhary et al. JOURNAL OF HOSPITAL INFECTION
- First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia
- (2016) Belinda Calvo et al. JOURNAL OF INFECTION
- Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi
- (2016) Nathan P. Wiederhold et al. Virulence
- Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
- (2015) Sharanya Chatterjee et al. BMC GENOMICS
- Targeting the Adaptability of Heterogeneous Aneuploids
- (2015) Guangbo Chen et al. CELL
- Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
- (2015) Kevin Kim et al. Annals of Clinical Microbiology and Antimicrobials
- Artemisinins, New Miconazole Potentiators Resulting in Increased Activity against Candida albicans Biofilms
- (2014) Kaat De Cremer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandin resistance
- (2014) Maiken C. Arendrup et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways
- (2014) Gajendra Kumar Azad et al. MOLECULAR BIOLOGY REPORTS
- High-Throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for Identification of Candida albicans Biofilm Inhibitors
- (2013) Samuel A. Siles et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species
- (2013) L. Drgona et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- A Repurposing Approach Identifies Off-Patent Drugs with Fungicidal Cryptococcal Activity, a Common Structural Chemotype, and Pharmacological Properties Relevant to the Treatment of Cryptococcosis
- (2012) Arielle Butts et al. EUKARYOTIC CELL
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
- (2011) Wee Gyo Lee et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
- (2011) M. Spitzer et al. Molecular Systems Biology
- Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus
- (2009) J. Meletiadis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Candida haemuloniiand Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features
- (2009) Mi‐Na Kim et al. CLINICAL INFECTIOUS DISEASES
- Growth Inhibitory Action of Ebselen on Fluconazole-Resistant Candida albicans: Role of the Plasma Membrane H+-ATPase
- (2009) Blase Billack et al. Microbial Drug Resistance
- Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital
- (2009) Kazuo Satoh et al. MICROBIOLOGY AND IMMUNOLOGY
- Ciclopirox for the treatment of superficial fungal infections: a review
- (2003) Aditya K. Gupta et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search